Postpartum Weight Loss and Exercise (PRIDE)

NCT ID: NCT01296516

Last Updated: 2021-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-02-28

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective is in comparison to a group of women not enrolled in the lifestyle intervention, 8 months of intensive lifestyle intervention aimed at promoting 7% weight loss through increased physical activity and dietary modification in women with a history of GDM will:

1. decrease body weight and
2. reduce the rate of metabolic abnormalities, 12 months after delivery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Glucose Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

A group matched for age and BMI will be selected to serve as control subjects in this study.

Group Type PLACEBO_COMPARATOR

Non-intervention group

Intervention Type BEHAVIORAL

A pedometer and written material on a healthy lifestyle.

Face-to-face group

Participants randomized to the face-to-face intervention will attend motivational meetings held once per week in Phase I and biweekly in Phase II. Behavioral sessions will be led by a trained interventionist and will take place at Pennington Biomedical Research Center.

Group Type ACTIVE_COMPARATOR

Face to face

Intervention Type BEHAVIORAL

Motivational meetings held once per week; Behavioral sessions weill be led by a trained interventionist.

Telehealth Group

Participants randomized to the Telehealth intervention will receive behavioral counseling through Trestletree, phone system.

Group Type ACTIVE_COMPARATOR

Telehelath Group

Intervention Type BEHAVIORAL

Participants will speak to Trestletree personnel once a week via phone.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-intervention group

A pedometer and written material on a healthy lifestyle.

Intervention Type BEHAVIORAL

Face to face

Motivational meetings held once per week; Behavioral sessions weill be led by a trained interventionist.

Intervention Type BEHAVIORAL

Telehelath Group

Participants will speak to Trestletree personnel once a week via phone.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Placebo Trestletree

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postpartum Women ≥18 years to 45 years (inclusive) of age who experienced GDM during index pregnancy
* English-speaking

Exclusion Criteria

* Women enrolled in COPSS-GDM will be excluded if they met the following criteria:


* History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic disorders, or cancer
* Regular use of medications for weight control or psychosis
* History or clinical manifestation of any eating disorder
* Smoking
* Pregnancy or pregnancy planned during the coming year
* Unwilling or unable to adhere to the clinical evaluation schedule over the twelve -month study period
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

THE C.B. AND IRENE PENNINGTON FOUNDATION

UNKNOWN

Sponsor Role collaborator

Pennington Biomedical Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Leanne Redman

Principle Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leanne M. Redman, PhD

Role: PRINCIPAL_INVESTIGATOR

Pennington Biomedical Research Center

Karen Elkind-Hirsh, PhD

Role: STUDY_DIRECTOR

Womans' Research Hospital

Catherine Chamagne, PhD

Role: STUDY_CHAIR

Pennington Biomedical Research Center

Timothy S. Church, MD, MPH, PhD

Role: STUDY_CHAIR

Pennington Biomedical Research Center

Eric Ravussin, PhD

Role: STUDY_CHAIR

Pennington Biomedical Reserach Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBRC 10041

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Black Women's Wellness Project
NCT04063059 COMPLETED NA
Weight Gain Prevention
NCT00606840 COMPLETED NA
Health After Birth Intervention Trial
NCT05137691 TERMINATED NA